登录后查看消息通知
搜索
常见问题
消息
登录
首页
/
数据集
/
Rates of hemorrhage in pituitary grands after OSI-930 administration.
Rates of hemorrhage in pituitary grands after OSI-930 administration.
收藏
Figshare
2023-03-16 更新
2026-04-28 收录
药物不良反应监测
出血风险评估
数据链接:
https://figshare.com/articles/dataset/Rates_of_hemorrhage_in_pituitary_grands_after_OSI-930_administration_/22287256
数据链接
链接失效反馈
官方服务:
问题咨询
购买咨询
在线客服
NEW
资源简介:
Rates of hemorrhage in pituitary grands after OSI-930 administration.
应用场景:
创建时间:
2023-03-16
相关数据集
Top 10 drugs most frequently causing ADR events in CCC.
药物不良反应监测
药物安全预警
Top 10 drugs most frequently causing ADR events in CCC.
NIAID Data Ecosystem
11
0
Description of ≥ graded 3 adverse events during sorafenib treatment (N,%) (See also S1 Table, for more details).
药物不良反应监测
靶向治疗安全性
ANC, absolute neutrophil count; AGC, absolute granulocyte count; AST, aspartate transaminase; ALT, alanine transaminase. Description of ≥ graded 3 adverse events during sorafenib treatment (N,%) (See
NIAID Data Ecosystem
5
0
Characteristics of adverse drug reaction cases to cefaclor and other 2 nd and 3 rd cephalosporins in the Korean Adverse Event Reporting System database for the most recent 5 years.
药物不良反应监测
头孢菌素类药物
Characteristics of adverse drug reaction cases to cefaclor and other 2nd and 3rd cephalosporins in the Korean Adverse Event Reporting System database for the most recent 5 years.
NIAID Data Ecosystem
3
0
Number of GIAE cases in patients receiving tirzepatide treatment in FAERS (2022–2024).
药物不良反应监测
替尔泊肽安全性评价
Number of GIAE cases in patients receiving tirzepatide treatment in FAERS (2022–2024).
Digital Science - Figshare
2026-03-27 更新
7
0
Main ADRs resulting in hospital admission.
药物不良反应监测
临床药物安全性
Main ADRs resulting in hospital admission.
Figshare
2020-03-24 更新
4
0
© 2023-2026 上海数据发展科技有限责任公司 版权所有
沪ICP备17003045号-15
沪公网安备31010402336585号
热门搜索
社区交流群
科研交流群
商业服务
数据资源
寻源服务
数据采集
标注服务
数据产品
代理销售
数据领域
凭证登记
数据产品
介绍推广